The Skin Cancer Education and Research Foundation – Home › Forums › Immunotherapy › Dosing and administration › Infusion times › Reply To: Infusion times
February 11, 2018 at 8:15 pm #4674
Expert NurseRajni Kannan
The flipped dose clinical trials allow for the Ipillimumab 1mg/kg to be given over 60 min. We have started to do more flipped dozing of Nivolumab 3mg/kg and Ipi 1mg/kg which we are seeing less toxicity with but what appears to be the same response rates to the FDA approved dosing.